Robust radiogenomics approach to the identification of EGFR mutations among patients with NSCLC from three different countries using topologically invariant Betti numbers.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 27 09 2020
accepted: 09 12 2020
entrez: 11 1 2021
pubmed: 12 1 2021
medline: 24 4 2021
Statut: epublish

Résumé

To propose a novel robust radiogenomics approach to the identification of epidermal growth factor receptor (EGFR) mutations among patients with non-small cell lung cancer (NSCLC) using Betti numbers (BNs). Contrast enhanced computed tomography (CT) images of 194 multi-racial NSCLC patients (79 EGFR mutants and 115 wildtypes) were collected from three different countries using 5 manufacturers' scanners with a variety of scanning parameters. Ninety-nine cases obtained from the University of Malaya Medical Centre (UMMC) in Malaysia were used for training and validation procedures. Forty-one cases collected from the Kyushu University Hospital (KUH) in Japan and fifty-four cases obtained from The Cancer Imaging Archive (TCIA) in America were used for a test procedure. Radiomic features were obtained from BN maps, which represent topologically invariant heterogeneous characteristics of lung cancer on CT images, by applying histogram- and texture-based feature computations. A BN-based signature was determined using support vector machine (SVM) models with the best combination of features that maximized a robustness index (RI) which defined a higher total area under receiver operating characteristics curves (AUCs) and lower difference of AUCs between the training and the validation. The SVM model was built using the signature and optimized in a five-fold cross validation. The BN-based model was compared to conventional original image (OI)- and wavelet-decomposition (WD)-based models with respect to the RI between the validation and the test. The BN-based model showed a higher RI of 1.51 compared with the models based on the OI (RI: 1.33) and the WD (RI: 1.29). The proposed model showed higher robustness than the conventional models in the identification of EGFR mutations among NSCLC patients. The results suggested the robustness of the BN-based approach against variations in image scanner/scanning parameters.

Identifiants

pubmed: 33428651
doi: 10.1371/journal.pone.0244354
pii: PONE-D-20-30432
pmc: PMC7799813
doi:

Substances chimiques

EGFR protein, human EC 2.7.10.1
ErbB Receptors EC 2.7.10.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0244354

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Diagn Pathol. 2015 Apr 24;10:36
pubmed: 25907563
Eur Respir J. 2019 Mar 28;53(3):
pubmed: 30635290
PLoS One. 2019 Jan 22;14(1):e0210720
pubmed: 30668605
Med Phys. 2018 Nov;45(11):5116-5128
pubmed: 30230556
Lancet Oncol. 2009 May;10(5):432-3
pubmed: 19410185
Thorax. 2003 Nov;58(11):920-36
pubmed: 14586042
Sci Rep. 2019 Jun 19;9(1):8764
pubmed: 31217445
Comput Med Imaging Graph. 2016 Mar;48:1-8
pubmed: 26745258
J Thorac Oncol. 2016 Jan;11(1):39-51
pubmed: 26762738
Oncologist. 2019 Nov;24(11):e1156-e1164
pubmed: 30936378
Med Phys. 2020 Jun;47(5):2197-2205
pubmed: 32096876
Transl Lung Cancer Res. 2015 Apr;4(2):156-64
pubmed: 25870798
Lung Cancer. 2019 Jun;132:28-35
pubmed: 31097090
Transl Oncol. 2017 Dec;10(6):886-894
pubmed: 28930698
Lung Cancer. 2017 Nov;113:37-44
pubmed: 29110846
PLoS One. 2015 May 04;10(5):e0124165
pubmed: 25938522
Radiology. 2016 Jul;280(1):271-80
pubmed: 26937803
Cell Mol Life Sci. 2008 May;65(10):1566-84
pubmed: 18259690
Phys Med. 2020 Jan;69:90-100
pubmed: 31855844
Sci Data. 2018 Oct 16;5:180202
pubmed: 30325352
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Ann Oncol. 2014 Sep;25(9):1681-1690
pubmed: 24718890
AJR Am J Roentgenol. 2011 Jun;196(6):W678-82
pubmed: 21606253
Ann Oncol. 2019 May;30(5):863-870
pubmed: 31987360
Phys Med Biol. 2015 Jul 21;60(14):5471-96
pubmed: 26119045
Sci Rep. 2019 Feb 4;9(1):1139
pubmed: 30718811
Sci Rep. 2018 Dec 17;8(1):17913
pubmed: 30559455
PLoS One. 2012;7(8):e43842
pubmed: 22952784
Int J Crit Illn Inj Sci. 2015 Jul-Sep;5(3):189-95
pubmed: 26557489
Nat Commun. 2014 Jun 03;5:4006
pubmed: 24892406
Tomography. 2016 Dec;2(4):430-437
pubmed: 28149958
Mayo Clin Proc. 2008 May;83(5):584-94
pubmed: 18452692
J Thorac Dis. 2014 Sep;6(9):1230-8
pubmed: 25276365
Invest Radiol. 2015 Nov;50(11):757-65
pubmed: 26115366
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
IEEE J Biomed Health Inform. 2020 Jun 16;PP:
pubmed: 32750940
J Digit Imaging. 2016 Aug;29(4):476-87
pubmed: 26847203
J Radiat Res. 2019 Jan 1;60(1):150-157
pubmed: 30247662
Lung Cancer. 2015 Mar;87(3):272-7
pubmed: 25582278

Auteurs

Kenta Ninomiya (K)

Division of Medical Quantum Science, Department of Health Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Hidetaka Arimura (H)

Faculty of Medical Sciences, Division of Medical Quantum Science, Department of Health Sciences, Kyushu University, Fukuoka, Japan.

Wai Yee Chan (WY)

Faculty of Medicine, Department of Biomedical Imaging, University of Malaya, Kuala Lumpur, Malaysia.

Kentaro Tanaka (K)

Department of Respiratory Medicine, Kyushu University Hospital, Fukuoka, Japan.

Shinichi Mizuno (S)

Division of Medical Sciences and Technology, Department of Health Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Nadia Fareeda Muhammad Gowdh (NF)

Faculty of Medicine, Department of Biomedical Imaging, University of Malaya, Kuala Lumpur, Malaysia.

Nur Adura Yaakup (NA)

Faculty of Medicine, Department of Biomedical Imaging, University of Malaya, Kuala Lumpur, Malaysia.

Chong-Kin Liam (CK)

Faculty of Medicine, Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Chee-Shee Chai (CS)

Faculty of Medicine and Health Science, Department of Medicine, University Malaysia Sarawak, Kota Samarahan, Sarawak, Malaysia.

Kwan Hoong Ng (KH)

Faculty of Medicine, Department of Biomedical Imaging, University of Malaya, Kuala Lumpur, Malaysia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH